跳至主要内容
临床试验/EUCTR2017-001565-25-IT
EUCTR2017-001565-25-IT进行中(未招募)1 期

Efficacy and safety of methoxyflurane vaporized (PENTHROX®) in the treatment of acute trauma pain in pre-hospital setting and in the emergency department in Italy: a multicentre, randomized, controlled, open-label study - MEDITA

MUNDIPHARMA PHARMACEUTICALS SR0 个研究点目标入组 272 人开始时间: 2018年3月2日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
272

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Written informed consent must be provided by each patient prior to any study-specific activity. In cases where the patient is unable to write autonomously, it must be obtained a verbal consent in presence of a witness that the patient will have to confirm autonomously as soon as (s)he is able
  • Stable, vigilant and collaborative patient i.e. able to understand and communicate with the examiner in order to carry out the study activities
  • Age = 18 years
  • Trauma to the limbs (fracture, dislocation, crushing, bruising) in a single district.
  • N.B. For recruiting, given the particular setting, no instrumental confirmation is required but suspicion of involvement of a single district is sufficient.
  • Moderate to severe pain, detected by the Numerical Rating Scale (NRS score =4)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 1
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 200
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 72

排除标准

  • Personal or family history (parents or siblings) for malignant hyperthermia.
  • History of severe adverse reactions to inhaled anesthetics.
  • History of renal failure
  • history of liver failure.
  • trauma risky dynamics (ejection from the vehicle, cabin deformation, death of an occupant of the same vehicle, motor vehicle / pedestrian or cyclist impact with a motor vehicle in motion, projection / overturn, fall from a height of> 3 meters, extraction on event place > 20 min).
  • Altered level of vigilance and / or conscience (GCS <15)
  • Symptomatic hypotension or Systolic Pressure <100 mm / Hg
  • Discomfort with FR> 20 and SatO2 in air <95%
  • Known pregnancy status.Note: a 1 day delay with respect to the planned menstruation date (28days since the beginning of the previous one) has to be considered a suspected pregnancy.
  • Hypersensitivity to methoxyflurane, to any fluorinated anesthetic or to the E321 butylhydroxytoluene excipient.
  • Current treatment with any analgesic for chronic pain or in the previous 5 hours (8 hours in the case of diclofenac).
  • Known allergy to both paracetamol and non-steroidal anti-inflammatory drugs or known hypersensitivity to morphine
  • All types of acute abdomen and paralytic ileus
  • Hearth failure
  • Recent (within2 months) biliary tract surgery
  • Current bronchial asthma attack
  • Uncontrolled epilepsy
  • Depressive state treated with IMAO (ongoing or interrupted less 3 wks ago)
  • Theatment with naltrexone
  • History of active or recurrent peptic ulcer/hemorrhage (2 or more episodes of documented ulceration or bleeing in the last 6 months)
  • Bleeding diathesis
  • Current Intensive diuretic therapy
  • Chronic dyspepsia, gastritis with significant episodes in the last 2 months
  • Leucopenia and thrombocytopenia, current hemorrhages
  • Current anticoagulant therapy

研究者

发起方
MUNDIPHARMA PHARMACEUTICALS SR

相似试验